The emergence of SARS-CoV-2 was unforeseen, and the worldwide outbreak of COVID-19 has already impacted thousands. In response to the desperate public need for rapid high-volume testing we have developed the Panther Fusion® SARS-CoV-2 assay, which enables labs to run up to 1,150 tests in 24 hours and attain a time-to-first result in 2.4 hours.

The Panther Fusion SARS-CoV-2 Assay is a real-time PCR in vitro diagnostic test intended for the qualitative detection of RNA from SARS-CoV-2 isolated and purified from nasopharyngeal and oropharyngeal swab specimens obtained from individuals who meet COVID-19 clinical and/or epidemiological criteria.1


Test More Patients in Less Time 

Now your lab can leverage the power of your Panther Fusion® system with this highly sensitive test that identifies the SARS-CoV-2 virus.1  Using the Panther Fusion system, healthcare providers can test for SARS-CoV-2 from the same patient sample and collection vial that they currently use to diagnose other common respiratory viruses with overlapping COVID-19 symptoms — boosting efficiency and increasing clinical insight. 


Flex Your Ability

  • Run multiple assays from one specimen.

  • Detect and differentiate between other respiratory illnesses.

  • Run alongside other PCR and TMA assays simultaneously.


Verified Sample Collection Types1

For use with nasopharyngeal and oropharyngeal swab samples.

verified sample collection tube

  • BD Universal Viral Transport System

  • COPAN Universal Transport Medium

  • Remel MicroTest M4, M4RT, M5 or M6 formulations

  • ✓ Aptima® Multitest Swab Specimen Collection Kit§


A Novel Virus

While there are still many unknown variables regarding SARS-CoV-2, it’s understood that the virus spreads easily from person-to-person and is believed to live in the air for several hours and on surfaces for as long as two to three days.2

What is known is that accurate tests are needed to help mitigate the spread of this global pandemic. Learn more about the Panther Fusion SARS-CoV-2 assay and how we can help you react quickly to this emerging health threat.